Skip to main content
Clinical Trials/NCT05995847
NCT05995847UnknownNot Applicable

The Effectiveness of Harmonica Playing in Improving Lung Function Among In-home Patients With Chronic Obstructive Pulmonary Disease

The First Affiliated Hospital of Guangzhou Medical University2 sites in 1 country248 target enrollmentStarted: December 5, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
248
Locations
2
Primary Endpoint
Change in FEV1 % predicted

Study Overview

Brief Summary

Although it has been documented that harmonica playing plays a role in the pulmonary rehabilitation (PR) of patients with chronic obstructive pulmonary disease (COPD), current studies are limited by small sample sizes, uncomprehensive outcome indicators, and short intervention durations. Thus, the investigators aim to compare the harmonica combination group with the basic-PR-care group in terms of improving health outcomes among COPD patients, such as lung function, self-efficacy, quality of life, compliance with training, and emotional distress.

Detailed Description

Chronic Obstructive Pulmonary Disease (COPD) is an avoidable and treatable condition characterized by chronic respiratory symptoms and airflow obstruction, primarily due to airway and/or alveolar abnormalities from toxic elements. Because of COPD's high prevalence and mortality, its prevention and treatment pose a global public health challenge that needs addressing.

Pulmonary rehabilitation (PR) is considered a cornerstone of COPD management because it effectively improves exercise tolerance, exercise-induced dyspnea, fatigue, and health-related quality of life. Inspiratory muscle training (IMT) plays an important role in PR. Studies suggest that harmonica playing can emulate inspiratory muscle training, enhancing pulmonary function in COPD patients. Additionally, as a music therapy approach, harmonica playing may alleviate the emotional distress often seen in these individuals.

However, existing studies haven't provided robust evidence to support harmonica playing's efficacy in enhancing COPD patients' health outcomes due to limitations like small sample sizes, non-trial study designs, incomplete outcomes, and short intervention durations. It remains unclear whether harmonica playing can improve COPD patients' physiological and psychological health outcomes.

This study's primary aim is to evaluate whether harmonica playing can boost the lung function of COPD patients compared to those only receiving basic PR care in the control group. The secondary aim is to investigate if harmonica playing can enhance other outcomes related to physical and psychological aspects, such as self-efficacy, quality of life, training compliance, and emotional distress.

Methods:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •● Clinical diagnosis of COPD.

Exclusion Criteria

  • •Individuals with a history of COPD exacerbation within the last 6 weeks. An exacerbation is defined as a deterioration in at least two respiratory symptoms that necessitate hospitalization.
  • •Individuals with comorbidities that affect physical activity, such as severe cardiac or neurological disorders, cancer, or musculoskeletal problems.
  • •Individuals with cognitive disorders.
  • •Individuals unable to speak or understand spoken/written Chinese.
  • •Individuals who have participated in pulmonary rehabilitation (or any other structured, disease-related physical training) within the previous 6 months.
  • •Individuals who have played the harmonica, or other similar instrument, regularly in the previous 6 months.

Arms & Interventions

harmonica combination group

Experimental

These patients will participate in a six-month harmonica playing program, in addition to receiving basic pulmonary rehabilitation (PR) care, which includes self-management education, exercise training, and breathing training, as well as routine follow-up. All training sessions are home-based and will take place five days per week for six months.

Intervention: Harmonica playing program plus basic PR care with routine follow-up (Behavioral)

basic-PR-care group

Active Comparator

These patients will receive basic pulmonary rehabilitation (PR) care, which includes self-management education, exercise training, and breathing training, as well as routine follow-up. All training sessions are home-based and will take place five days per week for six months.

Intervention: Basic PR care with routine follow-up (Behavioral)

Outcomes

Primary Outcomes

Change in FEV1 % predicted

Time Frame: At baseline, after 1 month, after 3 months, and after 6 months of intervention

The investigators will assess patients' lung function using a lung function detector to obtain the outcome of FEV1 % predicted.

Secondary Outcomes

  • Change in fatigue(At baseline, after 1 month, after 3 months, and after 6 months of intervention)
  • Change in psychological well-being(At baseline, after 1 month, after 3 months, and after 6 months of intervention)
  • Changes in clinical control(At baseline, after 1 month, after 3 months, and after 6 months of intervention)
  • Change in individual strength(At baseline, after 1 month, after 3 months, and after 6 months of intervention)
  • Change in self-efficacy(At baseline, after 1 month, after 3 months, and after 6 months of intervention)
  • Compliance and satisfaction(After 6 months of intervention)
  • Change in quality of life(At baseline, after 1 month, after 3 months, and after 6 months of intervention)
  • Change in inspiratory muscle strength(At baseline, after 1 month, after 3 months, and after 6 months of intervention)
  • Change in symptoms(At baseline, after 1 month, after 3 months, and after 6 months of intervention)
  • Change in level of physical activity(At baseline, after 1 month, after 3 months, and after 6 months of intervention)
  • Changes in levels of breathlessness(At baseline, after 1 month, after 3 months, and after 6 months of intervention)
  • Social support status(At baseline, after 1 month, after 3 months, and after 6 months of intervention)
  • Change in expiratory muscle strength(At baseline, after 1 month, after 3 months, and after 6 months of intervention)

Investigators

Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Zeng Qiuxuan

nurse-in-charge

The First Affiliated Hospital of Guangzhou Medical University

Study Sites (2)

Loading locations...

Similar Trials